{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:23:06Z","timestamp":1790223786741,"version":"4.1.0"},"reference-count":128,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403472"],"award-info":[{"award-number":["82403472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82403472"],"award-info":[{"award-number":["82403472"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019230","name":"Wuhan Union Hospital","doi-asserted-by":"publisher","award":["F00326027001"],"award-info":[{"award-number":["F00326027001"]}],"id":[{"id":"10.13039\/501100019230","id-type":"DOI","asserted-by":"publisher"}]},{"award":["F00326027001"],"award-info":[{"award-number":["F00326027001"]}],"id":[{"id":"https:\/\/ror.org\/0371fqr87","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Hubei Provincial Natural Science Foundation of China","award":["JCZRQN202500265"],"award-info":[{"award-number":["JCZRQN202500265"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Chronic liver diseases impose a considerable global public health burden, yet available treatment options remain largely inadequate. The gut microbiota exerts a key modulatory effect on liver disease pathogenesis via the gut-liver axis. Among them, Lachnospiraceae, a dominant bacterial family in the healthy adult gut, has drawn growing interest in recent years. Lachnospiraceae exert protective functions by producing short-chain fatty acids, participating in secondary bile acid conversion, and synthesizing active metabolites such as N-acetyl-glutamic acid, thereby maintaining intestinal barrier integrity and regulating host metabolic and immune homeostasis. Extensive evidence indicates that in cirrhosis, alcohol-associated liver disease, and metabolic dysfunction-associated steatotic liver disease, Lachnospiraceae abundance is consistently and significantly reduced, and this decrease is closely correlated with disease severity and adverse prognosis. In hepatocellular carcinoma, however, different members of Lachnospiraceae exhibit functional divergence, with some butyrate-producing genera decreasing while other subgroups may become enriched and influence the tumor immune microenvironment. Live biotherapeutic products based on Lachnospiraceae have achieved clinical breakthroughs in recurrent Clostridioides difficile infection and metabolic syndrome, providing important references for their translational application in liver diseases. This review systematically synthesizes the abundance changes and mechanisms of Lachnospiraceae across major liver diseases, evaluates their biomarker and therapeutic target potential, and seeks to provide fresh perspectives for precision microbiome-modulating strategies in chronic liver disease management.<\/jats:p>","DOI":"10.3390\/ijms27167175","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:32:16Z","timestamp":1786444336000},"page":"7175","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Lachnospiraceae in Liver Diseases: Recent Advances and Clinical Application Prospects"],"prefix":"10.3390","volume":"27","author":[{"given":"Jincheng","family":"Feng","sequence":"first","affiliation":[{"name":"Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Cao","sequence":"additional","affiliation":[{"name":"Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghe","family":"Deng","sequence":"additional","affiliation":[{"name":"Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Krag","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e70155","DOI":"10.1111\/liv.70155","article-title":"Global Burden of Chronic Liver Disease and Temporal Trends: A Population-Based Analysis from 1990 to 2021 with Projections to 2050","volume":"45","author":"Zhao","year":"2025","journal-title":"Liver Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e70001","DOI":"10.1111\/liv.70001","article-title":"The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021","volume":"45","author":"Tham","year":"2025","journal-title":"Liver Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/2050640614560452","article-title":"Managing complications in cirrhotic patients","volume":"3","author":"Angeli","year":"2015","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s11605-019-04295-w","article-title":"Impact of Surveillance in Chronic Hepatitis B Patients on Long-Term Outcomes After Curative Liver Resection for Hepatocellular Carcinoma","volume":"24","author":"Li","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bragazzi, M.C., Venere, R., Vignone, A., Alvaro, D., and Cardinale, V. (2023). Role of the Gut-Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202303.0164.v1"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Xu, M., Luo, K., Li, J., Li, Y., Zhang, Y., Yuan, Z., Xu, Q., and Wu, X. (2022). Role of Intestinal Microbes in Chronic Liver Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012661"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117284","DOI":"10.1016\/j.bcp.2025.117284","article-title":"New insights into gut-liver axis in advanced liver diseases: A promising therapeutic target","volume":"242","author":"Xing","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"110179","DOI":"10.1016\/j.jnutbio.2025.110179","article-title":"Composition, function, and detection methods of the intestinal barrier","volume":"149","author":"Sun","year":"2026","journal-title":"J. Nutr. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jare.2026.02.052","article-title":"Lacticaseibacillus paracasei 36 attenuates D-GalN\/LPS-induced acute liver injury in mice via suppressing the TLR4\/NF-\u03baB\/MAPK pathway and NLRP3 inflammasome activation through modulating the intestinal microbiota","volume":"84","author":"Wang","year":"2026","journal-title":"J. Adv. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3350\/cmh.2024.0716","article-title":"Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on \u201cGut microbiome and metabolome signatures in liver cirrhosis-related complications\u201d","volume":"31","author":"Lee","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"117897","DOI":"10.1016\/j.bcp.2026.117897","article-title":"Mechanism and interventions of the bile acid-gut-liver axis imbalance in the progression of non-alcoholic fatty liver disease","volume":"249","author":"Guo","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"105217","DOI":"10.1016\/j.critrevonc.2026.105217","article-title":"Microbiome-gut-liver axis in chronic inflammation and cancer immunotherapy: Multi-omics Insights and a translational roadmap toward personalized medicine","volume":"221","author":"Lou","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Xirouchakis, E., Pelekanos, A., Xirouchakis, S., Kranidioti, H., and Manolakopoulos, S. (2025). A Systematic Review of Microbiota in Cirrhosis: A Change Towards a More Pathogenic Predisposition. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020527"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Song, Y., Liu, S., Zhang, L., Zhao, W., Qin, Y., and Liu, M. (2024). The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: A systematic review and network meta-analysis. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1470185"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, P., Yang, C., Ren, K., Xu, M., Pan, C., Ye, X., and Li, L. (2024). Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1504948"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vacca, M., Celano, G., Calabrese, F.M., Portincasa, P., Gobbetti, M., and De Angelis, M. (2020). The Controversial Role of Human Gut Lachnospiraceae. Microorganisms, 8.","DOI":"10.3390\/microorganisms8040573"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/gbe\/evu050","article-title":"A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria","volume":"6","author":"Meehan","year":"2014","journal-title":"Genome Biol. Evol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.chom.2020.05.005","article-title":"Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity","volume":"28","author":"Sorbara","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1111\/1462-2920.15167","article-title":"Initial butyrate producers during infant gut microbiota development are endospore formers","volume":"22","author":"Appert","year":"2020","journal-title":"Environ. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zaplana, T., Miele, S., and Tolonen, A.C. (2023). Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1324396"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Rosenberg, E., DeLong, E.F., Lory, S., Stackebrandt, E., and Thompson, F. (2014). The Family Lachnospiraceae. The Prokaryotes: Firmicutes and Tenericutes, Springer.","DOI":"10.1007\/978-3-642-30120-9"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01514.x","article-title":"Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine","volume":"294","author":"Louis","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"001559","DOI":"10.1099\/mic.0.001559","article-title":"Roles of human colonic bacteria in pectin utilization and associated cross-feeding networks revealed using synthetic co-cultures","volume":"171","author":"Solvang","year":"2025","journal-title":"Microbiology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1002\/imt2.174","article-title":"Isolation of potentially novel species expands the genomic and functional diversity of Lachnospiraceae","volume":"3","author":"Lin","year":"2024","journal-title":"Imeta"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Nie, K., Ma, K., Luo, W., Shen, Z., Yang, Z., Xiao, M., Tong, T., Yang, Y., and Wang, X. (2021). Roseburia intestinalis: A Beneficial Gut Organism from the Discoveries in Genus and Species. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.757718"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/fmb-2016-0130","article-title":"Roseburia spp.: A marker of health?","volume":"12","author":"Smida","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/gmb.2023.14","article-title":"The butyrate-producing and spore-forming bacterial genus Coprococcus as a potential biomarker for neurological disorders","volume":"4","author":"Notting","year":"2023","journal-title":"Gut Microbiome"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/AEM.72.5.3593-3599.2006","article-title":"Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut","volume":"72","author":"Belenguer","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1099\/00207713-44-1-87","article-title":"Lachnospira pectinoschiza sp. nov., an anaerobic pectinophile from the pig intestine","volume":"44","author":"Cornick","year":"1994","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/1462-2920.14454","article-title":"Formate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co-cultures of acetogenic and amylolytic human colonic bacteria","volume":"21","author":"Mukhopadhya","year":"2019","journal-title":"Environ. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e0002923","DOI":"10.1128\/MRA.00029-23","article-title":"Complete genome sequence of the archetype bile acid 7\u03b1-dehydroxylating bacterium, Clostridium scindens VPI12708, isolated from human feces, circa 1980","volume":"12","author":"Hernandez","year":"2023","journal-title":"Microbiol. Resour. Announc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105985","DOI":"10.3748\/wjg.v31.i16.105985","article-title":"Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis","volume":"31","author":"Zhu","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gao, B., Wang, Z., Wang, K., Lei, Y., Zhuang, Y., Zhou, Z., and Chen, J. (2024). Relationships among gut microbiota, plasma metabolites, and juvenile idiopathic arthritis: A mediation Mendelian randomization study. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1363776"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Vilchez-Vargas, R., Salm, F., Znalesniak, E.B., Haupenthal, K., Schanze, D., Zenker, M., Link, A., and Hoffmann, W. (2022). Profiling of the Bacterial Microbiota along the Murine Alimentary Tract. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031783"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41598-022-07594-6","article-title":"Spatial distribution of live gut microbiota and bile acid metabolism in various parts of human large intestine","volume":"12","author":"Chinda","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"117166","DOI":"10.1016\/j.celrep.2026.117166","article-title":"Phage-related symbiosis and antagonism shape gut ecosystem dynamics in Lachnospiraceae and Bacteroidaceae","volume":"45","author":"Zhao","year":"2026","journal-title":"Cell Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"343ra382","DOI":"10.1126\/scitranslmed.aad7121","article-title":"Antibiotics, birth mode, and diet shape microbiome maturation during early life","volume":"8","author":"Bokulich","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2517821","DOI":"10.1080\/19490976.2025.2517821","article-title":"Lachnospiraceae bacterium alleviates alcohol-associated liver disease by enhancing N-acetyl-glutamic acid levels and inhibiting ferroptosis through the KEAP1-NRF2 pathway","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s40168-025-02220-9","article-title":"Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids","volume":"13","author":"Fitzgerald","year":"2025","journal-title":"Microbiome"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"157009","DOI":"10.1016\/j.phymed.2025.157009","article-title":"Jing An decoction alleviates neuroinflammation in Tourette syndrome by regulating butyrate-mediated microbiota-gut-brain axis","volume":"145","author":"Kang","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Xiang, W., Yang, Q., Ji, J., Qiao, H., Khan, A., Salama, E.S., Mao, C., Wu, Y., and Li, X. (2026). Food-Derived Limosilactobacillus fermentum GR-3 Enhances Anti-PD-1 Immunotherapy Efficacy. Probiotics Antimicrob. Proteins.","DOI":"10.1007\/s12602-026-11048-0"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1128\/AEM.68.10.5186-5190.2002","article-title":"Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine","volume":"68","author":"Duncan","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Singh, V., Lee, G., Son, H., Koh, H., Kim, E.S., Unno, T., and Shin, J.H. (2022). Butyrate producers, \u201cThe Sentinel of Gut\u201d: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1103836"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e00130-17","DOI":"10.1128\/mSystems.00130-17","article-title":"Colonic Butyrate-Producing Communities in Humans: An Overview Using Omics Data","volume":"2","author":"Vital","year":"2017","journal-title":"mSystems"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41564-023-01337-7","article-title":"Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut","volume":"8","author":"Foley","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.aohep.2019.06.020","article-title":"Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis","volume":"18","author":"Liu","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11892-011-0187-x","article-title":"Bile acid metabolism and the pathogenesis of type 2 diabetes","volume":"11","author":"Prawitt","year":"2011","journal-title":"Curr. Diab Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.reth.2025.08.011","article-title":"Microbiome-derived bile acids as endogenous regenerative mediators in liver repair","volume":"30","author":"Pandey","year":"2025","journal-title":"Regen. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mao, Q., Lin, B., Zhang, W., Zhang, Y., Zhang, Y., Cao, Q., and Xu, M. (2024). Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: Current evidence and perspectives. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1371574"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e0063423","DOI":"10.1128\/aem.00634-23","article-title":"Rumen Lachnospiraceae isolate NK3A20 exhibits metabolic flexibility in response to substrate and coculture with a methanogen","volume":"89","author":"Kaminsky","year":"2023","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"141933","DOI":"10.1016\/j.ijbiomac.2025.141933","article-title":"Synergistic regulation of colon microflora and metabolic environment by resistant starch and sodium lactate in hyperlipidemic rats","volume":"307","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e00051-17","DOI":"10.1128\/mSystems.00051-17","article-title":"Insights into Butyrate Production in a Controlled Fermentation System via Gene Predictions","volume":"2","author":"Ilhan","year":"2017","journal-title":"mSystems"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2460543","DOI":"10.1080\/19490976.2025.2460543","article-title":"Lachnospiraceae-bacterium alleviates ischemia-reperfusion injury in steatotic donor liver by inhibiting ferroptosis via the Foxo3-Alox15 signaling pathway","volume":"17","author":"Deng","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Gu, C., Zhou, Z., Yu, Z., He, M., He, L., Luo, Z., Xiao, W., Yang, Q., Zhao, F., and Li, W. (2022). The Microbiota and It\u2019s Correlation with Metabolites in the Gut of Mice with Nonalcoholic Fatty Liver Disease. Front. Cell. Infect. Microbiol., 12, Erratum in Front. Cell. Infect. Microbiol.\u00a02022, 12, 972118. https:\/\/doi.org\/10.3389\/fcimb.2022.972118.","DOI":"10.3389\/fcimb.2022.870785"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100448","DOI":"10.1016\/j.jhepr.2022.100448","article-title":"Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100377","DOI":"10.4254\/wjh.v17.i1.100377","article-title":"Gut microbiome composition in patients with liver cirrhosis with and without hepatic encephalopathy: A systematic review and meta-analysis","volume":"17","author":"Xu","year":"2025","journal-title":"World J. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e01021","DOI":"10.14309\/ctg.0000000000001021","article-title":"Alterations in the Gut Microbiota of Cirrhotic Patients With Sarcopenia and PH After TIPS","volume":"17","author":"Wang","year":"2026","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1946367","DOI":"10.1080\/19490976.2021.1946367","article-title":"Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice","volume":"13","author":"Singhal","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhang, L., Zi, L., Kuang, T., Wang, K., Qiu, Z., Wu, Z., Liu, L., Liu, R., Wang, P., and Wang, W. (2023). Investigating causal associations among gut microbiota, metabolites, and liver diseases: A Mendelian randomization study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1159148"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"140087","DOI":"10.1016\/j.ijbiomac.2025.140087","article-title":"Comparative study on the anti-alcoholic liver disease efficiency of the ethanol- and water-soluble polysaccharides from Baijiu vinasses","volume":"299","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1039\/D4FO02592J","article-title":"The alleviative effects of viable and inactive Lactobacillus paracasei CCFM1120 against alcoholic liver disease via modulation of gut microbiota and the Nrf2\/HO-1 and TLR4\/MyD88\/NF-\u03baB pathways","volume":"15","author":"Niu","year":"2024","journal-title":"Food Funct."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"144463","DOI":"10.1016\/j.foodchem.2025.144463","article-title":"Enhanced bioactivity of honeysuckle-Cassia seeds extracts through Lactobacillus acidophilus and Bacillus subtilis co-fermentation: Impact on alcoholic liver disease and gut microbiota","volume":"486","author":"Zhou","year":"2025","journal-title":"Food Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clnu.2025.01.022","article-title":"Protein supplementation differentially alters gut microbiota and associated liver injury recovery in mouse model of alcohol-related liver disease","volume":"46","author":"Mittal","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1021\/acs.jafc.5c13513","article-title":"UPLC-Q-TOF\/MS-Based Metabolomics and 16S rRNA Profiling Reveal that Corosolic Acid Ameliorates High-Fat Diet-Induced MASLD by Modulating the Gut-Liver Axis to Inhibit the cGAS-STING Pathway","volume":"74","author":"Cai","year":"2026","journal-title":"J. Agric. Food Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41538-026-00815-6","article-title":"Cinnamaldehyde mitigates MASLD through SIRT1\/FOXO1-induced autophagy and synergistic gut microbiota modulation","volume":"10","author":"Wang","year":"2026","journal-title":"npj Sci. Food"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"151338","DOI":"10.1016\/j.ijbiomac.2026.151338","article-title":"Mitigative effect of natural resistant starch from kudzu on intestinal-hepatic injury in mice exposed to high-fat diet and dextran sulfate sodium","volume":"353","author":"Dong","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"157987","DOI":"10.1016\/j.phymed.2026.157987","article-title":"Isorhamnetin alleviates diet induced MASLD in mice by modulating gut microbiota and bile acid metabolism","volume":"153","author":"Guo","year":"2026","journal-title":"Phytomedicine"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Dai, W., Cai, D., Zhou, S., Li, A., Xie, J., and Zhang, J. (2023). Uncovering a causal connection between the Lachnoclostridium genus in fecal microbiota and non-alcoholic fatty liver disease: A two-sample Mendelian randomization analysis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1276790"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100783","DOI":"10.1016\/j.gastha.2025.100783","article-title":"Integrating Gut Microbiome and Metabolome to Gain Insight into Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"4","author":"Zhang","year":"2025","journal-title":"Gastro Hep Adv."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chuaypen, N., Asumpinawong, A., Sawangsri, P., Khamjerm, J., Iadsee, N., Jinato, T., Sutheeworapong, S., Udomsawaengsup, S., and Tangkijvanich, P. (2024). Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031807"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13099-026-00798-5","article-title":"Clinical and microbial correlates of response to lifestyle intervention in pediatric metabolic dysfunction-associated steatotic liver disease","volume":"18","author":"Hahn","year":"2026","journal-title":"Gut Pathog."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3724\/abbs.2025183","article-title":"Gut microbiota and bile acids changes in MASLD mice model with hepatic PLD1 knockout","volume":"58","author":"Zhao","year":"2025","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13073-020-00796-5","article-title":"Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma","volume":"12","author":"Huang","year":"2020","journal-title":"Genome Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2147\/JHC.S485532","article-title":"Gut Microbiome and Hepatic Transcriptomic Determinants of HCC Development in Mice with Metabolic Dysfunction-Associated Steatohepatitis","volume":"11","author":"Dolapchiev","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1038\/s41598-023-34765-w","article-title":"Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e003334","DOI":"10.1136\/jitc-2021-003334","article-title":"Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers","volume":"9","author":"Mao","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Jiang, H., Song, T., Li, Z., An, L., He, C., and Zheng, K. (2023). Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1255650"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Shao, L., Ling, Z., Chen, D., Liu, Y., Yang, F., and Li, L. (2018). Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.03166"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13099-019-0337-2","article-title":"The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption","volume":"11","author":"Deng","year":"2019","journal-title":"Gut Pathog."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Liu, Y., Chen, Z., Li, C., Sun, T., Luo, X., Jiang, B., Liu, M., Wang, Q., Li, T., and Cao, J. (2025). Associations between changes in the gut microbiota and liver cirrhosis: A systematic review and meta-analysis. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-03589-5"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Chang, L., Liu, Y., Li, H., Yan, J., Wu, W., Chen, N., Ma, C., Zhao, X., Chen, J., and Zhang, J. (2025). Gut microbiome and its metabolites in liver cirrhosis: Mechanisms and clinical implications. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1717696"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Nishimura, N., Kaji, K., Kitagawa, K., Sawada, Y., Furukawa, M., Ozutsumi, T., Fujinaga, Y., Tsuji, Y., Takaya, H., and Kawaratani, H. (2021). Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136921"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/liv.14106","article-title":"Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids","volume":"39","author":"Jin","year":"2019","journal-title":"Liver Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients with Cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Litwinowicz, K., and Gamian, A. (2023). Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032461"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: A randomized trial","volume":"17","author":"Pande","year":"2023","journal-title":"Hepatol. Int."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e23100","DOI":"10.1590\/s0004-2803.24612023-100","article-title":"Comparison of gut microbiota in alcoholic and metabolic-dysfuncion associated steatotic liver disease in animal models","volume":"61","author":"Perlin","year":"2024","journal-title":"Arq. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal Microbiome Distinguishes Alcohol Consumption from Alcoholic Hepatitis But Does Not Discriminate Disease Severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"123100","DOI":"10.1016\/j.carbpol.2024.123100","article-title":"The efficient separation of bioactive components from Eucommia ulmoides Oliver using membrane filtration technology and its mechanisms in preventing alcoholic liver disease","volume":"351","author":"Le","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Wang, T., Jia, Z., An, C., Ren, P., Yang, Y., Wang, W., and Su, L. (2023). The Protective Effect of Auricularia cornea var. Li. Polysaccharide on Alcoholic Liver Disease and Its Effect on Intestinal Microbiota. Molecules, 28.","DOI":"10.3390\/molecules28248003"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Guo, Y., Zhang, N., and Pei, D. (2025). Gut microbiota heterogeneity in non-alcoholic fatty liver disease: A narrative review of drivers, mechanisms, and clinical relevance. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1645298"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e23100","DOI":"10.1038\/s41522-026-01059-8","article-title":"Characterization of gut microbiome signatures in metabolic dysfunction associated steatotic liver disease","volume":"12","author":"Ma","year":"2026","journal-title":"npj Biofilms Microbiomes"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/procel\/pwae058","article-title":"Investigating regional-specific gut microbial distribution: An uncharted territory in disease therapeutics","volume":"16","author":"Kuang","year":"2025","journal-title":"Protein Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"150147","DOI":"10.1016\/j.ijbiomac.2026.150147","article-title":"Kefiran, a polysaccharide from kefir grain, modulates gut microbiota and hepatic metabolism to mitigate metabolic dysfunction-associated steatotic liver disease","volume":"341","author":"Cui","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"117156","DOI":"10.1016\/j.biopha.2024.117156","article-title":"Bacteroides ovatus alleviates high-fat and high-cholesterol -induced nonalcoholic fatty liver disease via gut-liver axis","volume":"178","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Satthawiwat, N., Jinato, T., Sutheeworapong, S., Tanpowpong, N., Chuaypen, N., and Tangkijvanich, P. (2024). Distinct Gut Microbial Signature and Host Genetic Variants in Association with Liver Fibrosis Severity in Patients with MASLD. Nutrients, 16.","DOI":"10.3390\/nu16121800"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sun, Y.H., Ding, P.L., Wang, X., Wang, Y.R., Zhu, M.Z., Wang, K., Dai, L., Dang, Y.Q., Ji, G., and Li, M. (2026). Lingguizhugan Decoction Ameliorates MASLD by Modulating the Gut Microbiota and Enriching Non-12-OH Bile Acids to Activate TGR5-Mediated Thermogenesis. Pharmaceuticals, 19.","DOI":"10.3390\/ph19040523"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"155919","DOI":"10.1016\/j.phymed.2024.155919","article-title":"Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice","volume":"133","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"101490","DOI":"10.1016\/j.mam.2026.101490","article-title":"Gut microbiota dysbiosis in chronic liver disease: Mechanisms driving hepatocellular carcinoma progression and therapeutic implications of Chinese medicine","volume":"110","author":"Zheng","year":"2026","journal-title":"Mol. Aspects Med."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Fukui, H. (2019). Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?. Diseases, 7.","DOI":"10.3390\/diseases7040058"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"106000","DOI":"10.1016\/j.ijantimicag.2020.106000","article-title":"Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model","volume":"56","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Elsherbiny, N.M., Kamal El-Din, O.M., Hassan, E.A., Hetta, H.F., Alatawy, R., Sayed Ali, M.A., Alanazi, F.E., Abdel-Maksoud, M.S., Aljohani, H.M., and Badary, M.S. (2025). Direct-acting antiviral treatment significantly shaped the gut microbiota in chronic hepatitis C patients: A pilot study. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1664447"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.3748\/wjg.v27.i43.7446","article-title":"Overview of the microbiota in the gut-liver axis in viral B and C hepatitis","volume":"27","author":"Neag","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/jiab094","article-title":"Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with or Without Human Immunodeficiency Virus Coinfection","volume":"224","author":"Chuaypen","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"101494","DOI":"10.1016\/j.jhepr.2025.101494","article-title":"Restoration of the gut-microbiota-liver axis after hepatitis C virus eradication","volume":"7","author":"Inoue","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_114","first-page":"196","article-title":"Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study","volume":"46","author":"Pinchera","year":"2023","journal-title":"New Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"100752","DOI":"10.3748\/wjg.v31.i3.100752","article-title":"Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications","volume":"31","author":"Jiang","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3748\/wjg.v26.i2.199","article-title":"Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study","volume":"26","author":"Lv","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","article-title":"Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial","volume":"83","author":"Bajaj","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Arnold, J., McClure, S., Glazier, J., Ahan, R.E., Shakya, S., Villegas, D., Chen, T.L., Fuerte-Stone, J., McGann, R., and Mimee, M. (2025). Engineering butyrate-producing Lachnospiraceae to treat metabolic disease. bioRxiv.","DOI":"10.1101\/2025.11.08.687059"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","article-title":"SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection","volume":"386","author":"Feuerstadt","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial","volume":"329","author":"Louie","year":"2023","journal-title":"JAMA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41522-020-0127-0","article-title":"Treatment with Anaerobutyricum soehngenii: A pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome","volume":"6","author":"Gilijamse","year":"2020","journal-title":"npj Biofilms Microbiomes"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/gutjnl-2020-323297","article-title":"Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: A randomised double-blind placebo-controlled cross-over study","volume":"71","author":"Koopen","year":"2022","journal-title":"Gut"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1038\/s41467-022-32015-7","article-title":"Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota","volume":"13","author":"Hosomi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/jgh.14536","article-title":"Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats","volume":"34","author":"Zhang","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Islam, S.M.S., Ryu, H.M., Sayeed, H.M., Byun, H.O., Jung, J.Y., Kim, H.A., Suh, C.H., and Sohn, S. (2021). Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.712312"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41591-018-0324-z","article-title":"Healthy infants harbor intestinal bacteria that protect against food allergy","volume":"25","author":"Feehley","year":"2019","journal-title":"Nat. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"0127","DOI":"10.34133\/research.0127","article-title":"Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l-Serine-Mediated NK Cell Activation","volume":"6","author":"Liu","year":"2023","journal-title":"Research"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40168-025-02093-y","article-title":"Systems genetics uncovers associations among host amylase locus, gut microbiome, and metabolic traits in mice","volume":"13","author":"Zhang","year":"2025","journal-title":"Microbiome"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7175\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:34:44Z","timestamp":1786444484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":128,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167175"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167175","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}